Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
Management of Insomnia01:19

Management of Insomnia

244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

347
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
347
Understanding Sleep01:11

Understanding Sleep

227
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
227
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

153
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
153

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potent Anti-Glioblastoma Effects of Next-Generation MNK Inhibitors.

Cancers·2026
Same author

SLFN5 restrains type I interferon responses and promotes glioblastoma via its N-terminal Schlafen core domain.

Communications biology·2026
Same author

Multi-omics analysis reveals LARP1 as a key integrator of translation and metabolism in AML.

Oncogenesis·2026
Same author

Development of a Direct-to-Biology Platform to Discover Potent MNK Inhibitors.

Journal of medicinal chemistry·2026
Same author

PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.

Blood advances·2026
Same author

Schlafen 5 is an intracellular immune checkpoint and controls IFN responses in pancreatic ductal adenocarcinoma.

JCI insight·2026

Related Experiment Video

Updated: Jun 25, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.4K

Schlafens: Emerging Therapeutic Targets.

Ricardo E Perez1,2, Frank Eckerdt1,2, Leonidas C Platanias1,2,3

  • 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.

Cancers
|May 25, 2024
PubMed
Summary

Interferons (IFNs) impact cancer therapy by inhibiting cancer growth. Their target genes, Schlafens, are crucial for cell functions and are implicated in cancer, emerging as biomarkers and drug targets.

Keywords:
Schlafen (SLFN)cancerimmune therapyinterferon (IFN)

More Related Videos

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
08:58

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice

Published on: June 19, 2019

9.7K
The Sleep Nullifying Apparatus: A Highly Efficient Method of Sleep Depriving Drosophila
06:06

The Sleep Nullifying Apparatus: A Highly Efficient Method of Sleep Depriving Drosophila

Published on: December 14, 2020

3.4K

Related Experiment Videos

Last Updated: Jun 25, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.4K
Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
08:58

Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice

Published on: June 19, 2019

9.7K
The Sleep Nullifying Apparatus: A Highly Efficient Method of Sleep Depriving Drosophila
06:06

The Sleep Nullifying Apparatus: A Highly Efficient Method of Sleep Depriving Drosophila

Published on: December 14, 2020

3.4K

Area of Science:

  • Immunology and Cancer Biology
  • Cytokine Signaling and Gene Regulation

Background:

  • The interferon (IFN) family of cytokines has been studied for over 50 years for its role in cancer therapy.
  • IFNs inhibit malignant cell proliferation and modulate immune responses, influencing cancer progression and treatment.
  • Schlafen (SLFN) genes are transcriptional targets of IFNs, and their protein products play key roles in cellular processes.

Purpose of the Study:

  • To highlight research on the role of Schlafens in cancer.
  • To explore the potential of Schlafens as cancer biomarkers.
  • To present the rationale for developing drugs targeting Schlafen proteins in cancer therapy.

Main Methods:

  • Review of existing scientific literature on interferon signaling and Schlafen gene family.
  • Analysis of studies investigating the expression and function of Schlafen proteins in various cancers.
  • Examination of research linking Schlafen dysregulation to cancer pathophysiology and treatment response.

Main Results:

  • Schlafen proteins modulate critical cellular functions including proliferation, differentiation, immune response, viral replication, and chemosensitivity.
  • Abnormal expression of specific Schlafens is associated with the development and progression of diverse cancers.
  • Schlafens demonstrate potential as reliable biomarkers for cancer diagnosis and prognosis.

Conclusions:

  • Schlafens are emerging as significant players in cancer biology, influencing tumor growth and immune evasion.
  • The dysregulation of Schlafen expression highlights their contribution to cancer pathophysiology.
  • Schlafens represent promising novel biomarkers and therapeutic targets for the development of targeted cancer drugs.